Postoperative Adjuvant Sorafenib or Sunitinib for Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus: a Prospective Cohort Study

PURPOSE: To evaluate the efficacy and safety of antiangiogenic agents (sorafenib and sunitinib) as postoperative adjuvant therapy in patients with nonmetastatic renal cell carcinoma (RCC) and venous tumor thrombus (VTT). MATERIAL AND METHODS: From March 2006 to January 2016, 147 patients who met the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transl Oncol
Auteurs principaux: Gu, Liangyou, Li, Hongzhao, Chen, Luyao, Li, Xintao, Wang, Baojun, Huang, Qingbo, Zhang, Fan, Fan, Yang, Gao, Yu, Peng, Cheng, Ma, Xin, Zhang, Xu
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press 2017
Sujets:
Original article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5645483/
https://ncbi.nlm.nih.gov/pubmed/29035731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.09.009
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires